CME Group Inc (NASDAQ:CME) has earned a consensus rating of “Buy” from the thirteen research firms that are currently covering the stock, Marketbeat Ratings reports. Three equities research analysts have rated the stock with a hold rating and nine have given a buy rating to the company. The average twelve-month price target among brokerages that have covered the stock in the last year is $144.22.

Several brokerages have recently commented on CME. BidaskClub upgraded CME Group from a “hold” rating to a “buy” rating in a research note on Tuesday, January 9th. Zacks Investment Research upgraded CME Group from a “hold” rating to a “buy” rating and set a $164.00 target price for the company in a research note on Tuesday, January 2nd. Citigroup raised their target price on CME Group from $138.00 to $155.00 and gave the company a “buy” rating in a research note on Thursday, October 19th. Royal Bank of Canada raised their target price on CME Group from $135.00 to $147.00 and gave the company an “outperform” rating in a research note on Monday, October 16th. Finally, Barclays raised their target price on CME Group from $139.00 to $149.00 and gave the company an “overweight” rating in a research note on Tuesday, October 10th.

In other CME Group news, CFO John W. Pietrowicz sold 5,175 shares of CME Group stock in a transaction that occurred on Thursday, November 2nd. The shares were sold at an average price of $139.70, for a total transaction of $722,947.50. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, CFO John W. Pietrowicz sold 7,500 shares of CME Group stock in a transaction that occurred on Tuesday, January 9th. The stock was sold at an average price of $151.50, for a total transaction of $1,136,250.00. Following the transaction, the chief financial officer now directly owns 32,376 shares in the company, valued at approximately $4,904,964. The disclosure for this sale can be found here. In the last ninety days, insiders sold 42,603 shares of company stock worth $6,250,726. 0.57% of the stock is owned by insiders.

Several institutional investors have recently bought and sold shares of CME. Quadrant Capital Group LLC lifted its position in shares of CME Group by 13.6% during the 2nd quarter. Quadrant Capital Group LLC now owns 944 shares of the financial services provider’s stock worth $111,000 after buying an additional 113 shares in the last quarter. Valeo Financial Advisors LLC bought a new position in shares of CME Group during the 3rd quarter worth approximately $124,000. San Francisco Sentry Investment Group CA bought a new position in shares of CME Group during the 2nd quarter worth approximately $129,000. People s United Financial Inc. lifted its position in shares of CME Group by 11.5% during the 2nd quarter. People s United Financial Inc. now owns 1,063 shares of the financial services provider’s stock worth $133,000 after buying an additional 110 shares in the last quarter. Finally, Mckinley Capital Management LLC Delaware bought a new position in shares of CME Group during the 2nd quarter worth approximately $150,000. 82.78% of the stock is currently owned by hedge funds and other institutional investors.

Shares of CME Group (CME) traded up $2.07 on Friday, hitting $154.28. The stock had a trading volume of 1,558,652 shares, compared to its average volume of 1,350,000. The company has a debt-to-equity ratio of 0.11, a quick ratio of 1.05 and a current ratio of 1.05. The firm has a market cap of $53,210.00, a P/E ratio of 34.98, a PEG ratio of 2.05 and a beta of 0.72. CME Group has a 12 month low of $114.82 and a 12 month high of $155.29.

CME Group (NASDAQ:CME) last issued its earnings results on Thursday, October 26th. The financial services provider reported $1.19 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $1.16 by $0.03. The company had revenue of $890.80 million during the quarter, compared to the consensus estimate of $890.22 million. CME Group had a return on equity of 7.89% and a net margin of 40.94%. The firm’s revenue for the quarter was up 5.8% compared to the same quarter last year. During the same period last year, the business posted $1.05 EPS. equities research analysts predict that CME Group will post 4.75 earnings per share for the current fiscal year.

The firm also recently declared a dividend, which was paid on Tuesday, January 16th. Investors of record on Thursday, December 28th were given a $3.50 dividend. This is a boost from CME Group’s previous dividend of $3.25. The ex-dividend date was Wednesday, December 27th. CME Group’s dividend payout ratio (DPR) is presently 59.86%.

COPYRIGHT VIOLATION WARNING: This article was posted by TheOlympiaReport and is the property of of TheOlympiaReport. If you are reading this article on another publication, it was copied illegally and republished in violation of United States & international trademark & copyright law. The original version of this article can be viewed at https://theolympiareport.com/2018/01/20/cme-group-inc-cme-given-average-recommendation-of-buy-by-brokerages.html.

About CME Group

CME Group Inc, through its exchanges, provides products across all asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural products and metals. The Company’s segment primarily consists of the Chicago Mercantile Exchange Inc (CME), Board of Trade of the City of Chicago, Inc (CBOT), New York Mercantile Exchange, Inc (NYMEX) and Commodity Exchange, Inc (COMEX) exchanges.

Analyst Recommendations for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.